Objective: The Clinical Impairment Assessment (CIA) is a self-report measure of impairment secondary to eating disorder (ED) features. The purpose of this study was to identify the global CIA cut-off score that maximized sensitivity and specificity to discriminate impairment due to eating disorder pathology in a community versus clinical ED sample using receiver operating characteristic (ROC) analyses.
Method: Participants were 1,468 female community participants and 552 eating disorder patients.
Results: Mean global CIA scores were 5.17 (SD 7.61) and 32.50 (SD 10.20). The ROC analysis demonstrated excellent accuracy of the global CIA score (AUC = 0.97; 95% CI: 0.96-0.98). A cut-off score of 16.0 yielded a sensitivity of 0.91 (95% CI: 0.88-0.93) and a specificity of 0.91 (95% CI: 0.89-0.93).
Discussion: This study is the first to replicate findings from the original development study of the CIA and lends support to initial recommendations. Data provide strong evidence of the discriminant validity of the CIA and suggest the utility of assessing eating-disorder related impairment for classification purposes. © 2016 Wiley Periodicals, Inc. (Int J Eat Disord 2016; 49:635-638).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/eat.22517 | DOI Listing |
BMJ Open
December 2024
School of Nutrition, Federal University of Bahia, Salvador, Brazil.
Introduction: Eating disorders can be irreversible and, in many cases, fatal. However, the symptoms full recovery is possible, and early diagnosis is one, of many, important factors for the success of treatment. In this sense, the screening of risk behaviours arises as a relevant alternative to improve the prognosis of patients.
View Article and Find Full Text PDFObjective: To gain insights into the experience, and impact, of using security staff to facilitate physical restraints for nasogastric tube feeding.
Design: A cross-sectional design using 39 individual interviews, three online focus groups and three written submissions involving young people with lived experience (PWLE), parents/carers, paediatric staff and security staff involved in nasogastric feeding under restraint in paediatric settings in England. Qualitative semistructured interviews were transcribed and thematically analysed.
BMJ Open
December 2024
Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Objective: This study aimed to assess the association between ultraprocessed foods (UPF) consumption, eating disorders (EDs), food addiction and body image concerns.
Design: Systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
Data Sources: Medline, Scopus, Web of Science, EMBASE, LILACS and APA PsycInfo databases, for studies published between 2009 and July 2024.
J Eat Disord
January 2025
Dipartamento di Psicologia Generale, Università degli Studi di Padova, Padua, Italy.
Background: Poor quality of life in adults with anorexia nervosa (AN) and persistent high rates of readmission highlight the necessity of developing interventions to optimize treatment outcomes. ECHOMANTRA is a novel online intervention based on interventions for carers (Experienced Carers Helping Others, ECHO) and patients (Maudsley Model of Anorexia Nervosa Treatment for Adults, MANTRA) with anorexia nervosa. The objective of this paper is to describe the study protocol of a randomized control trial (RCT) aimed at evaluating the efficacy of an adaptation of the ECHOMANTRA for adults AN inpatients and outpatients, and their carers, to be implemented as an add-on to treatment-as-usual (TAU).
View Article and Find Full Text PDFJ Eat Disord
January 2025
School of Social Work, Faculty of Social Welfare and Health Sciences, University of Haifa, 3498838, Haifa, Israel.
Objective: The Eating Attitudes Test-26 (EAT-26) is considered the screening instrument of choice to identify eating disorders (ED) symptoms in clinical and community populations, showing a classical three-factor structure. This study assessed whether the factor structure of the EAT-26 in patients with ED was stable at admission and discharge from inpatient treatment.
Methods: We administered the EAT-26 to 207 female adolescents with ED at both admission and discharge.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!